Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis

by Jeffrey R. Curtis, Fenglong Xie, Jonathan Kay, Joel D Kallich
Published 2019-12-01

Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available

by Jeffrey R. Curtis, Fenglong Xie, Hong Zhou, David Salchert, Huifeng Yun
Published 2020-10-01

A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial

by Jeffrey R. Curtis, Christopher Herrem, ’Matladi N. Ndlovu, Cathy O’Brien, Yusuf Yazici
Published 2017-09-01

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians

by Emma Sullivan, Jim Kershaw, Stuart Blackburn, Jeannie Choi, Jeffrey R. Curtis, Susan Boklage
Published 2020-04-01

The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical p...

by Wenhui Wei, Emma Sullivan, Stuart Blackburn, Chieh-I Chen, James Piercy, Jeffrey R. Curtis
Published 2019-07-01

Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis

by Michael Grabner, Natalie N. Boytsov, Qing Huang, Xiang Zhang, Tingjian Yan, Jeffrey R. Curtis
Published 2017-05-01

Barriers to treatment optimization and achievement of patients’ goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry

by Kelly Gavigan, W. Benjamin Nowell, Mylene S. Serna, Jeffrey L. Stark, Mohamed Yassine, Jeffrey R. Curtis
Published 2020-01-01

Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability.

by Iris Navarro-Millán, Lisa J Herrinton, Lang Chen, Leslie Harrold, Liyan Liu, Jeffrey R Curtis
Published 2016-01-01

Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment

by Jeffrey R. Curtis, Kevin Winthrop, Cathy O’Brien, Matladi N. Ndlovu, Marc de Longueville, Boulos Haraoui
Published 2017-12-01

Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.

by Jun Won Park, Jeffrey R Curtis, Hajeong Lee, Jung-Kyu Lee, Yeong Wook Song, Eun Bong Lee
Published 2020-01-01

Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazo...

by Jun Won Park, Jeffrey R. Curtis, Min Jung Kim, Hajeong Lee, Yeong Wook Song, Eun Bong Lee
Published 2019-09-01

Factors associated with physicians’ prescriptions for rheumatoid arthritis drugs not filled by patients

by Hong J. Kan, Kirill Dyagilev, Peter Schulam, Suchi Saria, Hadi Kharrazi, David Bodycombe, Charles T. Molta, Jeffrey R. Curtis
Published 2018-05-01

Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study

by Jasvinder A. Singh, Rekha Ramachandaran, Shaohua Yu, Shuo Yang, Fenglong Xie, Huifeng Yun, Jie Zhang, Jeffrey R. Curtis
Published 2017-10-01

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study

by Marina Amaral de Ávila Machado, Cristiano Soares de Moura, Steve Ferreira Guerra, Jeffrey R. Curtis, Michal Abrahamowicz, Sasha Bernatsky
Published 2018-03-01

Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002–2017

by Jeffrey R Curtis, Namrata Singh, Charles F Lynch, Yubo Gao, Elizabeth Field, Brian K Link, Noel Weiss, Mary Vaughan-Sarrazin
Published 2020-08-01

Geographic Distribution of Endemic Fungal Infections among Older Persons, United States

by John W. Baddley, Kevin L. Winthrop, Nivedita M. Patkar, Elizabeth Delzell, Timothy Beukelman, Fenglong Xie, Lang Chen, Jeffrey R. Curtis
Published 2011-09-01

Patterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices

by Nick Bansback, Jeffrey R. Curtis, Jie Huang, Zeling He, Michael Evans, Tracy Johansson, Kaleb Michaud, Gabriela Schmajuk, Katherine P. Liao
Published 2020-02-01

Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower

by W. Benjamin Nowell, Kelly Gavigan, Carol L. Kannowski, Zhihong Cai, Theresa Hunter, Shilpa Venkatachalam, Julie Birt, Jennifer Workman, Jeffrey R. Curtis
Published 2021-02-01

Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis

by Jeffrey R. Curtis, Jan Michael Nebesky, Elodie de Bock, Christine de la Loge, Benoit Arnould, Robert Davey, Jenny Devenport, Attila Pethö-Schramm
Published 2021-08-01

Assessing a novel way to measure step count while walking using a custom mobile phone application.

by Christopher P Hurt, Donald H Lein, Christian R Smith, Jeffrey R Curtis, Andrew O Westfall, Jonathan Cortis, Clayton Rice, James H Willig
Published 2018-01-01